Moderna in advanced discussion to double COVID-19 vaccines for Europe
"We are scaling up our manufacturing capacity to address the global health crisis with a vaccine that is widely available once approved for use."
A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease (COVID-19), in Cambridge, Massachusetts, U.S., May 18, 2020(photo credit: REUTERS/BRIAN SNYDER)BySARAH CHEMLA
